Page last updated: 2024-10-31

midazolam and Kussmaul Aphasia

midazolam has been researched along with Kussmaul Aphasia in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research Excerpts

ExcerptRelevanceReference
" In this paper, we report on the dramatic, sudden resolution of PPCMS induced by midazolam administration in a boy who underwent posterior fossa surgery for choroid plexus papilloma of the fourth ventricle."3.85Sudden benzodiazepine-induced resolution of post-operative pediatric cerebellar mutism syndrome: a clinical-SPECT study. ( Clerico, A; Liberatore, M; Nicita, F; Paiano, M; Papoff, P; Piccirilli, M; Schiavetti, A; Spalice, A; Ullo, M, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nicita, F1
Paiano, M1
Liberatore, M1
Spalice, A1
Papoff, P1
Ullo, M1
Piccirilli, M1
Clerico, A1
Schiavetti, A1

Other Studies

1 other study available for midazolam and Kussmaul Aphasia

ArticleYear
Sudden benzodiazepine-induced resolution of post-operative pediatric cerebellar mutism syndrome: a clinical-SPECT study.
    Acta neurochirurgica, 2017, Volume: 159, Issue:3

    Topics: Adolescent; Benzodiazepines; Cerebellar Diseases; Cerebral Ventricle Neoplasms; Cranial Fossa, Poste

2017